Archives
-
Recombinant Mouse Sonic Hedgehog Workflows
2026-08-23
Build reproducible SHH dose–response assays and ex vivo genital-tubercle workflows with a defined morphogen input. This guide connects alkaline phosphatase benchmarking with comparative developmental experiments relevant to limb, brain, and congenital malformation research.
-
Self-Amplifying RNA Influenza Vaccines: 2026 Findings
2026-08-22
A 2026 study found that self-amplifying RNA vaccines produced durable, dose-sparing protection against seasonal influenza in mice, with the clearest advantage observed for influenza B. The work shows that vaccine modality and viral subtype interact strongly, while also defining important limits for translating low-dose preclinical results to human vaccine development.
-
ATP Solution for mRNA Workflows
2026-08-22
ATP Solution (100 mM) supports the energy-dependent steps behind IVT mRNA production, kinase testing, ligation, and phosphorylation assays. This practical guide connects reagent control with p21 mRNA–LNP research for localized bladder cancer, while separating product-backed specifications from workflow starting points.
-
β-Blocker Selectivity and Hematopoietic Recovery
2026-08-21
Nishino and colleagues show that nonselective β-adrenergic blockade can impair hematopoietic regeneration after transplantation, whereas β1-selective inhibition did not produce the same phenotype in their mouse and human analyses. The work links neural β2/β3 signaling with post-transplant recovery and suggests that blocker selectivity, transplant type, graft size, and graft-versus-host disease prophylaxis should be considered together.
-
Protease Inhibitor Cocktail: EDTA-Free Workflow Guide
2026-08-20
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic loss during protein extraction and protease-sensitive assays. Its EDTA-free formulation is suited to workflows that must retain divalent cations, but it is not a substitute for EDTA where chelation or metalloprotease inhibition is required.
-
Recombinant Mouse Sonic Hedgehog Workflows
2026-08-20
Build controlled SHH gain-of-function experiments for C3H10T1/2 cells, genital-tubercle explants, and comparative developmental models. This guide connects a validated alkaline phosphatase readout with practical reconstitution, dosing, storage, and troubleshooting strategies.
-
Urolithin A Workflows for Liver Fibrosis Research
2026-08-19
Build mitochondrial quality-control assays around Urolithin A while keeping glutamine metabolism and hepatic stellate cell biology analytically distinct. This workflow combines practical dosing, metabolic readouts, and troubleshooting guidance for hypothesis-driven fibrosis research.
-
HMGB1 Proteomics for Early Diabetic Nephropathy
2026-08-19
Peng et al. used serum quantitative proteomics, Mfuzz clustering, and weighted gene co-expression network analysis to identify proteins associated with diabetic nephropathy progression. HMGB1 was prioritized as a candidate early-monitoring biomarker and was further supported by high-glucose cell and animal experiments, although prospective clinical validation remains necessary.
-
Phosphatase Inhibitor Cocktail (2 Tubes, 100X)
2026-08-18
Phosphatase Inhibitor Cocktail (2 Tubes, 100X) (SKU K1015) is a dual-component reagent for reducing endogenous phosphatase activity during lysate preparation and supporting protein phosphorylation preservation. It is suited to research workflows such as immunoblotting, immunoprecipitation, kinase activity assays, and mass spectrometry, but it is not a universal phosphatase control, a substitute for rapid sample handling, or a diagnostic or medical reagent.
-
Recombinant Mouse SHH: Reliable Assay Design
2026-08-18
Learn how Recombinant Mouse SHH (SKU P1230) can support reproducible alkaline phosphatase, proliferation, viability, and developmental signaling experiments. This scenario-based guide connects product specifications with comparative SHH evidence while clarifying dose selection, controls, storage, and interpretation limits.
-
H 89 2HCl: A Causal Probe of PKA Signaling
2026-08-17
H 89 2HCl enables mechanistic cAMP-dependent protein kinase inhibition studies beyond simple phosphoprotein measurement. This article explains how to use it as a causal probe for glucocorticoid-regulated Kv2.1–CaV1.2 signaling while managing concentration-dependent off-target effects.
-
Lambda Protein Phosphatase for BMAL1 Validation
2026-08-17
Use Lambda Protein Phosphatase and λ-PPase as a practical dephosphorylation control for BMAL1 condensate studies, phospho-antibody testing, and functional protein assays. The workflow combines supplier-defined activity benchmarks with controls that distinguish phosphorylation dependence from protein loss, denaturation, or nonspecific detection.
-
Elbasvir–Grazoprevir: Evidence, Mechanism, and Scope
2026-08-16
The 2021 review of elbasvir–grazoprevir integrates mechanism, pharmacokinetics, clinical efficacy, resistance, and safety across HCV treatment populations. Its central conclusion is that complementary NS5A and NS3/4A inhibition provides a well-tolerated, high-efficacy option for genotype 1 and 4 infection, with particular relevance to renal impairment and selected comorbid populations.
-
Shh, Fgf10 and Fgfr2 in Species-Specific Penile Development
2026-08-15
The 2025 Cells study compares guinea pig and mouse genital tubercle development to explain why the two species form the penile urethra differently. Its combination of spatial expression analysis, quantitative PCR, and ex vivo protein or inhibitor perturbation implicates differential Shh and Fgf10/Fgfr2 signaling in urethral groove and prepuce morphogenesis.
-
BKT140 (BL-8040) CXCR4 Antagonist
2026-08-14
BKT140, also called BL-8040 and TF 14016, is an orally bioavailable CXCR4 antagonist for oncology and hematopoietic stem cell research. It blocks CXCR4-linked migration and survival biology while supporting assays of tumor behavior and blood-cell mobilization.